| Year |
Citation |
Score |
| 2020 |
Oh ES, Rosenberg PB, Rattinger GB, Stuart EA, Lyketsos CG, Leoutsakos JS. Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD). Journal of the American Geriatrics Society. PMID 33382921 DOI: 10.1111/jgs.16970 |
0.326 |
|
| 2020 |
Banning LCP, Ramakers IHGB, Rosenberg PB, Lyketsos CG, Leoutsakos JS. Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer's disease dementia. International Journal of Geriatric Psychiatry. PMID 32869375 DOI: 10.1002/Gps.5418 |
0.429 |
|
| 2019 |
Leoutsakos JS, Wise EA, Lyketsos CG, Smith GS. Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia. International Journal of Geriatric Psychiatry. PMID 31452260 DOI: 10.1002/Gps.5203 |
0.446 |
|
| 2019 |
Wang Y, Haaksma ML, Ramakers IHGB, Verhey FRJ, van de Flier WM, Scheltens P, van Maurik I, Olde Rikkert MGM, Leoutsakos JS, Melis RJF. Cognitive and functional progression of dementia in two longitudinal studies. International Journal of Geriatric Psychiatry. PMID 31318090 DOI: 10.1002/Gps.5175 |
0.351 |
|
| 2019 |
Haaksma ML, Rizzuto D, Leoutsakos JS, Marengoni A, Tan ECK, Olde Rikkert MGM, Fratiglioni L, Melis RJF, Calderón-Larrañaga A. Predicting Cognitive and Functional Trajectories in People With Late-Onset Dementia: 2 Population-Based Studies. Journal of the American Medical Directors Association. PMID 31109912 DOI: 10.1016/J.Jamda.2019.03.025 |
0.438 |
|
| 2019 |
Wise EA, Rosenberg PB, Lyketsos CG, Leoutsakos J. Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 11: 333-339. PMID 31024987 DOI: 10.1016/J.Dadm.2019.02.006 |
0.455 |
|
| 2019 |
Samus QM, Sloan D, Leoutsakos J, Black B, Johnston D. Common Unmet Needs Of Dementia Caregivers And How These Differ By Disease Stage And Race Innovation in Aging. 3. DOI: 10.1093/Geroni/Igz038.2027 |
0.35 |
|
| 2018 |
Haaksma ML, Leoutsakos JS, Bremer JAE, Aalten P, Ramakers IHGB, Verhey FRJ, Olde Rikkert MGM, Melis RJF. The clinical course and interrelations of dementia related symptoms - CORRIGENDUM. International Psychogeriatrics. 1. PMID 30520402 DOI: 10.1017/S1041610218001771 |
0.355 |
|
| 2018 |
Oeltzschner G, Wijtenburg SA, Mikkelsen M, Edden RAE, Barker PB, Joo JH, Leoutsakos JS, Rowland LM, Workman CI, Smith GS. Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla. Neurobiology of Aging. 73: 211-218. PMID 30390554 DOI: 10.1016/J.Neurobiolaging.2018.09.027 |
0.31 |
|
| 2018 |
Leoutsakos JS, Yan H, Anderson WS, Asaad WF, Baltuch G, Burke A, Chakravarty MM, Drake KE, Foote KD, Fosdick L, Giacobbe P, Mari Z, McAndrews MP, Munro CA, Oh ES, et al. Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation. Journal of Alzheimer's Disease : Jad. PMID 29914028 DOI: 10.3233/Jad-180121 |
0.324 |
|
| 2018 |
Samus QM, Black BS, Reuland M, Leoutsakos JS, Pizzi L, Frick KD, Roth DL, Gitlin LN, Lyketsos CG, Johnston D. MIND at Home-Streamlined: Study protocol for a randomized trial of home-based care coordination for persons with dementia and their caregivers. Contemporary Clinical Trials. PMID 29783091 DOI: 10.1016/J.Cct.2018.05.009 |
0.315 |
|
| 2018 |
Haaksma ML, Calderón-Larrañaga A, Olde Rikkert MGM, Melis RJF, Leoutsakos JS. Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. International Journal of Geriatric Psychiatry. PMID 29761569 DOI: 10.1002/Gps.4893 |
0.415 |
|
| 2018 |
Lafaille-Magnan M, Leoutsakos JS, Fontaine D, Madjar C, Kat J, Tremblay-Mercier J, Savard M, Brandt J, Breitner JCS. P1-585: Crosstalk Between English And French Forms Of The Rbans In An Alzheimer'S Disease Prevention Trial Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.597 |
0.316 |
|
| 2018 |
Haaksma ML, Rizutto D, Leoutsakos JS, Marengoni A, Tan ECK, Rikkert MGMO, Fratiglioni L, Melis RJF, Larrañaga AC. P1-012: Predictors Of Cognitive And Functional Decline In Incident Dementia Patients: An Analysis Of Two Swedish Population-Based Cohorts Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.013 |
0.387 |
|
| 2017 |
Haaksma ML, Vilela LR, Marengoni A, Calderón-Larrañaga A, Leoutsakos JS, Olde Rikkert MGM, Melis RJF. Comorbidity and progression of late onset Alzheimer's disease: A systematic review. Plos One. 12: e0177044. PMID 28472200 DOI: 10.1371/Journal.Pone.0177044 |
0.41 |
|
| 2017 |
Haaksma ML, Leoutsakos JS, Bremer JA, Aalten P, Ramakers IH, Verhey FR, Olde Rikkert MG, Melis RJ. The clinical course and interrelations of dementia related symptoms. International Psychogeriatrics. 1-8. PMID 28285610 DOI: 10.1017/S1041610217000321 |
0.391 |
|
| 2017 |
Haaksma M, Leoutsakos J, Rikkert MO, Melis RJ. Latent Classes Of Dementia Course Show An Optimistic Prognosis For The Majority Of Patients Innovation in Aging. 1: 346-347. DOI: 10.1093/Geroni/Igx004.1269 |
0.338 |
|
| 2017 |
Haaksma ML, Leoutsakos JS, Larrañaga AC, Rikkert MGMO, Melis RJF. Latent Classes Of Dementia Course Show An Optimistic Prognosis For The Majority Of Patients Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2014 |
0.338 |
|
| 2016 |
Gross AL, Mungas DM, Leoutsakos JS, Albert MS, Jones RN. Alzheimer's disease severity, objectively determined and measured. Alzheimer's & Dementia (Amsterdam, Netherlands). 4: 159-168. PMID 27830173 DOI: 10.1016/J.Dadm.2016.08.005 |
0.364 |
|
| 2016 |
Nowrangi MA, Rosenberg PB, Leoutsakos JS. Subtle changes in daily functioning predict conversion from normal to mild cognitive impairment or dementia: an analysis of the NACC database. International Psychogeriatrics / Ipa. 1-10. PMID 27585497 DOI: 10.1017/S1041610216000995 |
0.431 |
|
| 2016 |
Yesavage JA, Taylor JL, Friedman L, Rosenberg PB, Lazzeroni LC, Leoutsakos JS, Kinoshita LM, Perlow MJ, Munro CA, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, et al. Principal components analysis of agitation outcomes in Alzheimer's disease. Journal of Psychiatric Research. 79: 4-7. PMID 27115509 DOI: 10.1016/J.Jpsychires.2016.04.004 |
0.318 |
|
| 2015 |
Forrester SN, Gallo JJ, Smith GS, Leoutsakos JS. Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 26209222 DOI: 10.1016/J.Jagp.2015.05.007 |
0.411 |
|
| 2015 |
Lyketsos C, Smith GS, Fosdick L, Leoutsakos JS, Munro C, Oh E, Drake K, Rosenberg P, Anderson WS, Salloway S, Pendergrass JC, Burke A, Wolk D, Foote K, Tang-Wai D, et al. DT-01-05: Deep brain stimulation targeting the fornix for mild Alzheimer's disease: Initial results of the advance randomized controlled trial Alzheimer's & Dementia. 11: P332-P333. DOI: 10.1016/J.Jalz.2015.08.155 |
0.303 |
|
| 2015 |
Leoutsakos JS, Forrester SN, Geda YE, Lyketsos C. Nps in normal cognition and the risk of developing MCI and dementia in the presence of late-onset nps Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.441 |
0.352 |
|
| 2015 |
Steinberg MI, Leoutsakos JS. The association between general medical health and course of cognition, function, and neuropsychiatric symptoms in the cache county dementia progression study Alzheimers & Dementia. 11: 261. DOI: 10.1016/J.Jalz.2015.07.335 |
0.428 |
|
| 2015 |
Forrester SN, Leoutsakos JS. Sex differences in neuropsychiatric symptoms in MCI and risk of dementia Alzheimers & Dementia. 11: 672. DOI: 10.1016/J.Jalz.2015.06.998 |
0.356 |
|
| 2015 |
Gross AL, Mungas D, Albert MS, Leoutsakos JS, Jones RN. Alzheimer disease severity objectively determined and measured Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.1849 |
0.313 |
|
| 2014 |
Hochstetler H, Wang S, Yu P, Trzepacz PT, Case M, Henley D, Degenhardt E, Leoutsakos JS, Lyketsos C. Empirically Defining Trajectories Of Late-Life Cognitive And Functional Decline Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1250 |
0.358 |
|
| 2013 |
Leoutsakos J, Han D, Tighe S, Lyketsos C. Plasma markers and cognitive decline in the ADAPT clinical trial Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.446 |
0.327 |
|
| 2013 |
Marano C, Workman C, Lyman C, Narrow T, Zhou Y, Munro C, Dannals R, Holt D, Leoutsakos J, Lyketsos C, Wong D, Smith G. Cortical Beta-Amyloid Deposition in Late-Life Depression The American Journal of Geriatric Psychiatry. 21: S127. DOI: 10.1016/J.Jagp.2012.12.169 |
0.407 |
|
| 2012 |
Rosenberg PB, Mielke MM, Han D, Leoutsakos JS, Lyketsos CG, Rabins PV, Zandi PP, Breitner JC, Norton MC, Welsh-Bohmer KA, Zuckerman IH, Rattinger GB, Green RC, Corcoran C, Tschanz JT. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. International Journal of Geriatric Psychiatry. 27: 1248-57. PMID 22374884 DOI: 10.1002/Gps.3769 |
0.579 |
|
| 2011 |
Johnston D, Samus QM, Morrison A, Leoutsakos JS, Hicks K, Handel S, Rye R, Robbins B, Rabins PV, Lyketsos CG, Black BS. Identification of community-residing individuals with dementia and their unmet needs for care. International Journal of Geriatric Psychiatry. 26: 292-8. PMID 20658473 DOI: 10.1002/Gps.2527 |
0.385 |
|
| 2010 |
de Medeiros K, Robert P, Gauthier S, Stella F, Politis A, Leoutsakos J, Taragano F, Kremer J, Brugnolo A, Porsteinsson AP, Geda YE, Brodaty H, Gazdag G, Cummings J, Lyketsos C. The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. International Psychogeriatrics / Ipa. 22: 984-94. PMID 20594384 DOI: 10.1017/S1041610210000876 |
0.317 |
|
| Show low-probability matches. |